Status
Recruiting
Phase
N/A
Study type
Observational
Enrollment
40
Sex
Women only
Ages
Adults (Child, Adult, Older Adult)
Primary completion
2025-12-30
Last update
2025-03-19

What this trial studies

The objectives are to evaluate whether variations in vaginal and/or urinary and/or fecal microbiome predispose postmenopausal women to recurrent cystitis. This will be explored using comparison of microbiome profiles between those with recurrent UTI compared to age-matched women without recurrent UTI.

Conditions in scope

  • Urinary Tract Infections
  • Menopause

Interventions

  • Not specified in the public record.

Who can join

Women only · Adults (Child, Adult, Older Adult) · Accepts healthy volunteers.

Inclusion criteria

  • Menopausal status
  • Sterile urine cultures, normal urinalysis, and negative sexually-transmitted PCR urine assay

Exclusion criteria

  • Neurogenic bladder condition
  • Known immunodeficiencies
  • Usage of antibiotics or probiotics within the previous month
  • Known renal calculi or anatomic malformations
  • \- A prior history of UTIs or other urologic abnormalities.

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

CityState / RegionFacilitySite status
Jerusalem Jerusalem Hadassah Medical Center Recruiting

Status & timeline

  • Overall status: Recruiting
  • Study type: Observational
  • Phase: N/A
  • Start date: 2021-08-01
  • Primary completion: 2025-12-30
  • Last update posted: 2025-03-19
  • First posted: 2020-03-12

Lead sponsor: Hadassah Medical Organization (Other)

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

  • Characterization of the microbiome using molecular methods. (1 year)
    Comparison of microbiome profiles between those with rUTI compared to healthy controls.

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.

Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT04305808 before contacting a site.

ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.